| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e1120710706a835896ce34eebd78390
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b5be8da8252280fab2cab5208010bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ddbeb7a5705bf2f6de81ed96620e637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8ad6c95489f4afe8cfc50aa19e8e3d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6002b70fcb442eacb1a40c282bbf9647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfb47c84e5744717235d206b662b2bbc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-00 |
| filingDate |
2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6729983c665d84111cc706fbef3a5129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0586f502aa2a89a7dd4262d0351d2ff7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8ccffab736e6a303033256906f080d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69fe9b7143892221f0fdf054a920952a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ccfb604eb8f3e50e20df8c7b6ed0569 |
| publicationDate |
2008-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008059521-A2 |
| titleOfInvention |
Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin |
| abstract |
The present invention relates to a novel process for the preparation of moxifloxacin hydrochloride compound of formula-1 through novel quinoline carboxamide intermediate compounds of general formula-2. The present invention provides the process for the preparation of novel quinoline carboxamide intermediate compounds of general formula-2. The present invention also relates to a novel process for the preparation of anhydrous form of moxifloxacin hydrochloride and a novel crystalline form of moxifloxacin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102030751-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212990-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104507938-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101435244-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022323448-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2154137-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015093669-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102030751-B |
| priorityDate |
2006-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |